Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: Cellular responses to neurotoxicants malathion and lead acetate

NeuroToxicology

Volumn 32, Issue 1, 2011, Pages 58-67

  Balbuena, Pergentino ^a   Li, Wen ^a   Ehrich, Marion ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

BBB; Endothelial cells; Lead acetate; Malathion; Tight junctions

Indexed keywords

CLAUDIN 5; LEAD ACETATE; MALATHION; OCCLUDIN; PROTEIN ZO1; PROTEIN ZO2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN STEM RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DISRUPTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE; CLAUDINS; ENDOTHELIAL CELLS; MALATHION; MEMBRANE PROTEINS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; ORGANOMETALLIC COMPOUNDS; PHOSPHOPROTEINS; PROTEIN MODIFICATION, TRANSLATIONAL; RATS; TIGHT JUNCTIONS;

RATTUS;

EID: 78951486139     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.10.004     Document Type: Article

References (57)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood- brain barrier. Nat Rev Neurosci 2006, 7:41-53.
2. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002, 200:629-638.
3. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 2003, 58:484-498.
4. Alavijeh M.S., Chishty M., Qaiser M.Z., Palmer A.M. Drug metabolism and pharmacokinetics, the blood-brain-barrier, and central nervous system drug discovery. NeuroRx 2005, 2:554-571.
5. Ando-Akatsuka Y., Saitou M., Hirase T., Kishi M., Sakaqkibara A., Itoh M., Yonemura S., Furuse M., Tsukita S. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J Cell Biol 1996, 133:43-48.
6. Balbuena P., Li W., Magnin-Bissel G., Meldrum B., Ehrich M. Comparison of two blood-brain barrier in vitro systems: cytotoxicity and transfer assessments of malathion/oxon and lead acetate. Toxicol Sci 2010, 114:260-271.
7. Balda M.S., Anderson J.M. Two classes of tight junctions are revealed by ZO1 isoforms. Am J Physiol 1993, 264:C918-C924.
8. Balda S.M., Matter K. Tight junctions. J Cell Sci 1998, 111:541-547.
9. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview of structure, regulation, and clinical implications. Neurobiol Dis 2004, 16:1-13.
10. Barbosa F., Gerlach R.F., Tanus-Santos J.E. Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations. Basic Clin Pharmacol Toxicol 2006, 98:559-564.
11. Bouldin T.W., Mushak P., O'tuama L.A., Krigman M.R. Blood-brain barrier dysfunction in acute lead encephalopathy: a reappraisal. Environ Health Perspect 1975, 12:81-88.
12. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 1969, 40:648-677.
13. Chen F., Ohashi N., Li W., Eckman C., Nguyen J.H. Disruption of occludin and claudin 5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 2009, 50:1914-1923.
14. Eddleston M., Buckley N.A., Eyer P., Dawson A.H. Management of acute organophosphorus pesticide poisoning. Lancet 2008, 3781:597-607.
15. Ehrich M. Organophosphates. Encyclopedia of Toxicology 2005, vol. 2:308-311. Academic Press, San Diego.
16. El-Fawal H.A.N., Correll L., Gay L., Ehrich M. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol Appl Pharmacol 1990, 103:132-142.
17. Environmental Protection Agency (2000-2001). Pesticide market estimates. Pesticide industry sales webpage. Retrieved August 10, 2009, from http://www.epa.gov/oppbead1/pestsales/01pestsales/usage2001_3.htm.
18. Fanning A.S., Little B.P., Rahner C., Utepbergenov D., Walther Z., Anderson J.M. The unique-5 and -6 motifs of ZO1 regulate tight junction strand localization and scaffold properties. Mol Biol Cell 2007, 18:721-731.
19. Filippelli G.M., Laidlaw M.A. The elephant in the playground: confronting lead-contaminated soils as an important source of lead burdens to urban populations. Perspect Biol Med 2009, 53:31-45.
20. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after cerebral ischemia and reperfusion. Brain Res 1999, 842:92-100.
21. Furuse M., Fujita K., Hiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141:1539-1550.
22. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993, 123:1777-1788.
23. Gilbert M.E., Mack C.M., Lasley S.M. Chronic developmental lead exposure increases the threshold for long term potentiation in rat dentate gyrus in vivo. Brain Res 1996, 736:118-124.
24. Gilbert M.E., Mack C.M. Chronic lead exposure accelerates decay of long term potentiation in rat dentate gyrus in vivo. Brain Res 1998, 789:139-149.
25. Goldstein G.W., Asbury A.K., Diamond I. Pathogenesis of lead encephalopathy: uptake of lead and reaction of brain capillaries. Arch Neurol 1974, 31:382-389.
26. Goldstein G.W. Evidence that lead acts as a calcium substitute in second messenger metabolism. Neurotoxicology 1993, 14:97-101.
27. Gunnell D., Eddleston M., Phillips M.R., Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007, 7:357-372.
28. Haskins J., Gu L., Wittchen E.S., Hibbard J., Stevenson B.R. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO1 and occludin. J Cell Biol 1998, 141:199-208.
29. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173-185.
30. Itoh M., Furose M., Morita K., Kubota K., Saitou M., Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO1, ZO-2, and ZO-3 with the COOH termini of claudins. J Cell Biol 1999, 147:1351-1363.
31. Jesaitis L.A., Goodenough D.A. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO1 and the Drosophila discs-large tumor suppressor protein. J Cell Biol 1994, 124:949-962.
32. Kerper L.E., Hinkle P.M. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol Appl Pharmacol 1997, 146:127-133.
33. Kniesel U., Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000, 20:57-76.
34. Kohn E.C., Jacobs W., Kim Y.S., Alessandro R., Stetler-Stevenson W.G., Liotta L.A. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem 1994, 269:21505-21511.
35. Liebner S., Kniesel U., Kalbacher H., Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol 2000, 79:707-717.
36. T method. Methods 2001, 25:402-408.
37. Lochhead J.J., McCaffrey G., Quigley C.E., Finch J., Demarco K.M., Nametz N., Davis T.P. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 2010, 30:1625-1636.
38. McCaffrey G., Willis C.L., Staatz W.D., Nametz N., Quigley C.A., Hom S., Lochhead J.J., Davis T.P. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 2009, 110:58-71.
39. Morita K., Furuse M., Fujimoto K., Tsukita S. Claudin multigene family encoding four transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci 1999, 96:511-516.
40. Morita K., Sasaki H., Furose M., Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999, 147:185-194.
41. Musch M.W., Walsh-Reitz M.M., Chang E.B. Roles of ZO1, occludin, and actin in oxidant-induced barrier disruption. Am J Physiol Gastrointest Liver Physiol 2006, 290:222-231.
42. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660.
43. Omidi Y., Barar J., Ahmadian S., Heidari H.R., Gumbleton M. Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells. Cell Biochem Funct 2008, 26:381-391.
44. Parran D.K., Magnin G., Li W., Jortner B.S., Ehrich M. Chlorpyrifos alters functional integrity and structure of an in vitro model: co-cultures of bovine endothelial cells and neonatal rat astrocytes. Neurotoxicology 2005, 26(77-88):291.
45. Petroianu G.A., Lorke D.E., Hasa M.Y., Adem A., Sheen R., Nurulain S.M., Kalasz H. Paraoxon has a minimal effect on pralidoxime brain concentration in rats. J Appl Toxicol 2007, 27:350-357.
46. Schanne F.A.X., Long G.J., Rosen J.F. Lead-induced rise in intracellular free calcium is mediated trough activation of protein kinase C in osteoblastic bone cells. Biochim Biophys Acta 1997, 1360:247-254.
47. 2+/cAMP response element binding protein in cultured neurons. Toxicol Appl Pharmacol 2002, 182:176-185.
48. Shi L.Z., Zheng W. Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier in vitro. Hum Exp Toxicol 2007, 26:159-167.
49. Stevenson B.R., Siliciano J.D., Mooseker M.S., Goodenough D.A. Identification of ZO1: a higher molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986, 103:755-766.
50. 2+ signaling in the regulation of endothelial permeability. Vascul Pharmacol 2003, 39:173-185.
51. Toscano C.D., Guilarte T. Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev 2005, 49:529-554.
52. Tsukita S., Furose M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000, 149:13-16.
53. Wachtel M., Frei K., Ehler E., Fontana A., Winterhalter K., Gloor S.M. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci 1999, 112:4347-4356.
54. Wang W., Duan B., Xu H., Xu L., Xu T. Calcium-permeable acid-sending ion channel is a molecular target of the neurotoxic metal ion lead. J Biol Chem 2006, 281:2497-2505.
55. Wolburg H., Lippoldt A., Ebnet K. Tight junctions and the blood-brain barrier. Tight Junctions 2006, 175-195. Springer Science+Business Media, New York. L. Gonzalez-Mariscal (Ed.).
56. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002, 38:323-337.
57. Yang J., Aschner M. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro models for studies on chlorpyrifos transport. Neurotoxicology 2003, 24:741-745.